Clough Capital Partners L P acquired a new position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 107,580 shares of the medical device company’s stock, valued at approximately $10,037,000. DexCom accounts for […]